Lastly, the partial rescue observed within the PKM2 expression studies indicate that other PSAT1 activities contribute to EGFR-activated NSCLC motility that are independent of nuclear PKM2, which may include putative nuclear-specific PSAT1 function(s). Here, PKM is linked to non-small cell lung carcinoma.